Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 117

1.

Hypoxia inducible factor one alpha and human viral pathogens.

Morinet F, Parent M, Pillet S, Koken M, Lebbé C, Capron C.

Curr Res Transl Med. 2017 Jan - Mar;65(1):7-9. doi: 10.1016/j.retram.2016.11.002. Epub 2017 Mar 8. Review.

PMID:
28340697
2.

TLR3 and skin features.

Morinet F.

Curr Res Transl Med. 2016 Oct - Dec;64(4):167. doi: 10.1016/j.retram.2016.11.001. Epub 2016 Dec 7. No abstract available.

PMID:
27939453
3.

Oxygen, a regulator of viral gene expression?

Morinet F, Parent M, Lebbé C, Pillet S, Koken M, Capron C.

Curr Res Transl Med. 2016 Jul - Sep;64(3):165-166. doi: 10.1016/j.retram.2016.06.001. Epub 2016 Sep 28. No abstract available.

PMID:
27765278
4.

Ex vivo gene therapy in France.

Morinet F, Larghero J.

Curr Res Transl Med. 2016 Jul - Sep;64(3):121. doi: 10.1016/j.retram.2016.08.005. No abstract available.

PMID:
27765270
5.

[Chronic fatigue syndrome: A new disorder?]

de Korwin JD, Chiche L, Banovic I, Ghali A, Delliaux S, Authier FJ, Cozon G, Hatron PY, Fornasieri I, Morinet F.

Rev Med Interne. 2016 Dec;37(12):811-819. doi: 10.1016/j.revmed.2016.05.003. Epub 2016 May 31. French.

PMID:
27260787
6.

Update of the human parvovirus B19 biology.

Servant-Delmas A, Morinet F.

Transfus Clin Biol. 2016 Feb;23(1):5-12. doi: 10.1016/j.tracli.2015.11.006. Epub 2016 Jan 6. Review.

PMID:
26778837
7.

Paradoxical simultaneous regression and progression of lesions in a phase II study of everolimus in classic Kaposi sarcoma.

Mourah S, Porcher R, Battistella M, Kerob D, Guillot B, Jouary T, Agbalika F, Morinet F, Furlan V, Teisserenc HM, Dupin N, Lebbé C.

Br J Dermatol. 2015 Nov;173(5):1284-7. doi: 10.1111/bjd.13897. Epub 2015 Aug 19. No abstract available.

PMID:
25970141
8.

Oxygen and viruses: a breathing story.

Morinet F, Parent M, Bergeron C, Pillet S, Capron C.

J Gen Virol. 2015 Aug;96(8):1979-82. doi: 10.1099/vir.0.000172. Epub 2015 May 1. Review.

PMID:
25934794
9.

Aging of the brain, dementias, role of infectious proteins: facts and theories.

Morinet F.

Interdiscip Top Gerontol. 2014;39:177-86. doi: 10.1159/000358905. Epub 2014 May 13. Review.

PMID:
24862020
10.

Prions: a model of conformational disease?

Morinet F.

Pathol Biol (Paris). 2014 Apr;62(2):96-9. doi: 10.1016/j.patbio.2014.02.003. Epub 2014 Mar 20. Review.

PMID:
24656441
11.

[Sixty years of Pathologie Biologie].

Farge-Bancel D, Verrecchia F, Robert L, Morinet F.

Pathol Biol (Paris). 2014 Apr;62(2):59. doi: 10.1016/j.patbio.2014.02.004. Epub 2014 Mar 20. French. No abstract available.

PMID:
24656440
12.

Why do some human viruses remain recalcitrant to cultivation?

Morinet F, Capron C, Mazure NM, Pillet S.

Clin Infect Dis. 2014 Mar;58(5):752-3. doi: 10.1093/cid/cit802. Epub 2013 Dec 12. No abstract available.

PMID:
24336825
13.

Health-care access for migrants in France.

de Celeyran FT, Girardeau Y, Khan S, Morinet F, Georges-Tarragano C.

Lancet. 2013 Nov 23;382(9906):1704. doi: 10.1016/S0140-6736(13)62402-2. No abstract available.

PMID:
24268001
14.

[The role of protease-activated receptors (PAR) in antiviral immunity: the coxackievirus B-3 cardiomyopathy model].

Morinet F.

Pathol Biol (Paris). 2013 Dec;61(6):227. doi: 10.1016/j.patbio.2013.06.001. Epub 2013 Jul 25. French. No abstract available.

PMID:
23890989
15.

Oxygen tension level and human viral infections.

Morinet F, Casetti L, François JH, Capron C, Pillet S.

Virology. 2013 Sep;444(1-2):31-6. doi: 10.1016/j.virol.2013.06.018. Epub 2013 Jul 11. Review.

16.

[Interferon-ε, a weapon against sexually transmitted diseases?].

Morinet F.

Pathol Biol (Paris). 2013 Jun;61(3):87. doi: 10.1016/j.patbio.2013.03.004. Epub 2013 Apr 12. French. No abstract available.

17.

[Bacteriophage therapy and diabetic foot ulcer].

Morinet F.

Pathol Biol (Paris). 2013 Apr;61(2):37. doi: 10.1016/j.patbio.2013.03.002. Epub 2013 Apr 4. French. No abstract available.

PMID:
23562346
18.

[Genetic background and infectious diseases].

Morinet F.

Pathol Biol (Paris). 2013 Jan;61(1):1-2. doi: 10.1016/j.patbio.2013.01.006. Epub 2013 Feb 8. French. No abstract available.

PMID:
23399410
19.

[Cancerology: targets and targeted treatments].

Bedairia N, Morinet F, Marty M.

Pathol Biol (Paris). 2012 Aug;60(4):215-6. doi: 10.1016/j.patbio.2012.05.005. Epub 2012 Jun 26. French. No abstract available.

PMID:
22738994
20.

Concise review: Anemia caused by viruses.

Morinet F, Leruez-Ville M, Pillet S, Fichelson S.

Stem Cells. 2011 Nov;29(11):1656-60. doi: 10.1002/stem.725. Review.

21.

Advances in human B19 erythrovirus biology.

Servant-Delmas A, Lefrère JJ, Morinet F, Pillet S.

J Virol. 2010 Oct;84(19):9658-65. doi: 10.1128/JVI.00684-10. Epub 2010 Jul 14. Review.

22.

[Influenza viruses: short symposium].

Morinet F.

Pathol Biol (Paris). 2010 Apr;58(2):e49. doi: 10.1016/j.patbio.2010.01.008. Epub 2010 Mar 19. French. No abstract available.

PMID:
20303673
23.

[Emergent viruses, a continuous challenge].

Morinet F, Agut H.

Pathol Biol (Paris). 2009 Mar;57(2):115-6. doi: 10.1016/j.patbio.2008.07.018. Epub 2008 Sep 27. French. No abstract available.

PMID:
18824309
24.

Human B19 erythrovirus in vitro replication: what's new?

Pillet S, Fichelson S, Morinet F, Young NS, Zhi N, Wong S.

J Virol. 2008 Sep;82(17):8951-3. doi: 10.1128/JVI.00929-08. No abstract available.

25.

Hypoxia enhances human B19 erythrovirus gene expression in primary erythroid cells.

Pillet S, Le Guyader N, Hofer T, NguyenKhac F, Koken M, Aubin JT, Fichelson S, Gassmann M, Morinet F.

Virology. 2004 Sep 15;327(1):1-7.

26.

Surveillance network for herpes simplex virus resistance to antiviral drugs: 3-year follow-up.

Danve-Szatanek C, Aymard M, Thouvenot D, Morfin F, Agius G, Bertin I, Billaudel S, Chanzy B, Coste-Burel M, Finkielsztejn L, Fleury H, Hadou T, Henquell C, Lafeuille H, Lafon ME, Le Faou A, Legrand MC, Maille L, Mengelle C, Morand P, Morinet F, Nicand E, Omar S, Picard B, Pozzetto B, Puel J, Raoult D, Scieux C, Segondy M, Seigneurin JM, Teyssou R, Zandotti C.

J Clin Microbiol. 2004 Jan;42(1):242-9.

27.

Efficacy and safety of lowering immunosuppression to treat CMV infection in renal transplant recipients on valaciclovir prophylaxis: a pilot study.

Anglicheau D, Lautrette A, Scieux C, Flamant M, Morinet F, Legendre C.

Nephrol Dial Transplant. 2003 Aug;18(8):1654-6.

PMID:
12897109
28.
29.

High frequency of a 30-bp deletion of Epstein-Barr virus latent membrane protein 1 gene in primary HIV non-Hodgkin's brain lymphomas.

Vallat-Decouvelaere AV, Bretel MA, Vassias I, Laplanche JL, Polivka M, Wassef M, Brunet M, Thiebaut JB, Gosselin B, Morinet F, Mikol J.

Neuropathol Appl Neurobiol. 2002 Dec;28(6):471-9.

PMID:
12445163
30.

Lowering immunosuppression is safe and effective to treat altered pattern of CMV infection in renal transplant recipients on valaciclovir prophylaxis.

Anglicheau D, Lautrette A, Scieux C, Thervet E, Martinez F, Flamant M, Morinet F, Legendre C.

Transplant Proc. 2002 Nov;34(7):2826-7. No abstract available.

PMID:
12431624
31.

Spontaneous resolution of hemophagocytic syndrome associated with acute parvovirus B19 infection and concomitant Epstein-Barr virus reactivation in an otherwise healthy adult.

Larroche C, Scieux C, Honderlick P, Piette AM, Morinet F, Blétry O.

Eur J Clin Microbiol Infect Dis. 2002 Oct;21(10):739-42. Epub 2002 Sep 26. Review.

PMID:
12415473
32.

Parvovirus B19 and erythroid cells.

Pillet S, Morinet F.

Pathol Biol (Paris). 2002 Jun;50(5):349-56. Review.

PMID:
12116854
33.

The human parvovirus B19 and its interactions in vivo.

Morinet F.

Pathol Biol (Paris). 2002 Jun;50(5):283-4. No abstract available.

PMID:
12116846
34.

Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.

Chen Y, Scieux C, Garrait V, Socié G, Rocha V, Molina JM, Thouvenot D, Morfin F, Hocqueloux L, Garderet L, Espérou H, Sélimi F, Devergie A, Leleu G, Aymard M, Morinet F, Gluckman E, Ribaud P.

Clin Infect Dis. 2000 Oct;31(4):927-35. Epub 2000 Oct 10.

PMID:
11049772
35.

Molecular biology of erythroviruses.

Morinet F, Pallier C, Foulon-Sol N, Pillet S.

Contrib Microbiol. 2000;4:123-32. Review. No abstract available.

PMID:
10941574
36.

Usefulness of the cytomegalovirus (CMV) antigenemia assay for predicting the occurrence of CMV disease and death in patients with AIDS.

Chevret S, Scieux C, Garrait V, Dahel L, Morinet F, Modaï J, Decazes JM, Molina JM.

Clin Infect Dis. 1999 Apr;28(4):758-63.

PMID:
10825035
37.

Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human parvovirus B19.

Sol N, Le Junter J, Vassias I, Freyssinier JM, Thomas A, Prigent AF, Rudkin BB, Fichelson S, Morinet F.

J Virol. 1999 Oct;73(10):8762-70.

38.

Successful treatment of adenovirus disease with intravenous cidofovir in an unrelated stem-cell transplant recipient.

Ribaud P, Scieux C, Freymuth F, Morinet F, Gluckman E.

Clin Infect Dis. 1999 Mar;28(3):690-1. No abstract available.

PMID:
10194105
39.

Squamous cell carcinomas after allogeneic bone marrow transplantation for aplastic anemia: further evidence of a multistep process.

Socié G, Scieux C, Gluckman E, Soussi T, Clavel C, Saulnier P, Birembault P, Bosq J, Morinet F, Janin A.

Transplantation. 1998 Sep 15;66(5):667-70.

PMID:
9753353
40.

Regulation of human B19 parvovirus promoter expression by hGABP (E4TF1) transcription factor.

Vassias I, Hazan U, Michel Y, Sawa C, Handa H, Gouya L, Morinet F.

J Biol Chem. 1998 Apr 3;273(14):8287-93.

41.

Characterization of cis-acting and NS1 protein-responsive elements in the p6 promoter of parvovirus B19.

Gareus R, Gigler A, Hemauer A, Leruez-Ville M, Morinet F, Wolf H, Modrow S.

J Virol. 1998 Jan;72(1):609-16.

42.

Low prevalence of active parvovirus B19 infection in HIV-infected patients.

Raguin G, Leruez-Ville M, Gregoire V, Deplanche M, Leport C, Morinet F, Vilde JL.

Eur J Clin Microbiol Infect Dis. 1997 Oct;16(10):760-2.

PMID:
9405950
43.

The 3' untranslated region of the B19 parvovirus capsid protein mRNAs inhibits its own mRNA translation in nonpermissive cells.

Pallier C, Greco A, Le Junter J, Saib A, Vassias I, Morinet F.

J Virol. 1997 Dec;71(12):9482-9.

44.

[Mechanisms of viral diseases and means of natural defense].

Morinet F.

Rev Prat. 1997 Mar 15;47(6):618-21. French.

PMID:
9183935
45.

[Viruses and macrophages].

Morinet F, Kirn A.

Pathol Biol (Paris). 1997 Feb;45(2):101. French. No abstract available.

PMID:
9247030
46.

[Nervous system lymphoma in HIV infection].

Mikol J, Polivka M, Gyuris A, Minarovits J, Morinet F.

Arch Anat Cytol Pathol. 1997;45(2-3):164-73. French.

PMID:
9382609
47.

Establishment of a cell line expressing human parvovirus B19 non-structural protein from an inducible promoter.

Leruez-Ville M, Vassias I, Pallier C, Cecille A, Hazan U, Morinet F.

J Gen Virol. 1997 Jan;78 ( Pt 1):215-9.

PMID:
9010306
48.

Absence of picornavirus genome in pityriasis rosea.

Aractingi S, Morinet F, Mokni M, Tieng V, Flageul B, Fermand JP, Dubertret L.

Arch Dermatol Res. 1996 Dec;289(1):60-1. No abstract available.

PMID:
9017139
49.

EBV reactivation associated with Hodgkin's disease relapse and fatal hemophagocytic syndrome.

Mounier N, Cazals D, Pautier P, Morinet F, Cayuela JM, Gossot D, Brice P.

Leukemia. 1996 Nov;10(11):1848. No abstract available.

PMID:
8892695
50.

Immunohistochemical and virological study of skin in the papular-purpuric gloves and socks syndrome.

Aractingi S, Bakhos D, Flageul B, Vérola O, Brunet M, Dubertret L, Morinet F.

Br J Dermatol. 1996 Oct;135(4):599-602.

PMID:
8915154

Supplemental Content

Loading ...
Support Center